GeneDx Holdings(us:WGS)
77.40
+2.79%
Updated on 2024-12-22
Open:72.35
Close:77.40
High:78.75
Low:72.25
Pre Close:75.30
Volume:693134.00
Amount:53.44M
Turnover:2.52%
Shares:27.47M
MarketCap:2.13B
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 97 | 16278335 | 60.45% | 39 | 24 | 23 |
| 2024-03-31 | 67 | 13908270 | 53.24% | 20 | 16 | 17 |
| 2023-12-31 | 59 | 12440532 | 47.89% | 10 | 8 | 25 |
| 2023-09-30 | 62 | 13944603 | 53.89% | 5 | 17 | 25 |
| 2023-06-30 | 96 | 14056968 | 54.57% | 14 | 0 | 82 |
| 2023-03-31 | 104 | 470853937 | 58.99% | 17 | 39 | 35 |
| 2022-12-31 | 111 | 143018689 | 36.81% | 15 | 25 | 49 |
| 2022-09-30 | 116 | 158250588 | 41.49% | 7 | 32 | 51 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Casdin Capital, Llc | 3136411 | 12.01% | 40900 | 1.32% |
| 2024-03-31 | Corvex Management Lp | 2473781 | 9.47% | 0 | |
| 2024-03-31 | Oracle Investment Management Inc | 1126607 | 4.31% | 948253 | 531.67% |
| 2024-03-31 | Goldman Sachs Group Inc | 1125115 | 4.31% | -561716 | -33.30% |
| 2024-03-31 | Blackstone Inc. | 835062 | 3.20% | 0 | |
| 2024-03-31 | Morgan Stanley | 793481 | 3.04% | 9353 | 1.19% |
| 2024-03-31 | Soleus Capital Management, L.P. | 783376 | 3.00% | 723376 | 1205.63% |
| 2024-03-31 | Vanguard Group Inc | 707612 | 2.71% | 28678 | 4.22% |
| 2024-03-31 | Deerfield Management Company, L.P. (Series C) | 643110 | 2.46% | 0 | |
| 2024-03-31 | Gagnon Securities Llc | 556305 | 2.13% | 207027 | 59.27% |
About
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
Address:North Tower,333 Ludlow Street,8th floor
Website:http://www.genedx.com
Market Movers